Who owns EIKON THERAPEUTICS INC?
- Ticker: EIKN
- CUSIP Number: 282564103
Tip: Access positions for across all investors
Analyze quarterly positions in Eikon Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Eikon Therapeutics stock
Who bought or sold EIKON THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| FMR | 3.8M | $41M | 100% | Mar 2026 |
|
| BlackRock | 3.3M | $35M | 100% | Mar 2026 |
|
| Foresite Capital Management IV | 1.9M | $21M | 100% | Mar 2026 |
|
| Merck & Co | 1.7M | $18M | 100% | Mar 2026 |
|
| Foresite Capital Management V | 1.3M | $14M | 100% | Mar 2026 |
|
| Capital World Investors | 1.1M | $12M | 100% | Mar 2026 |
|
| Alliancebernstein | 1.0M | $11M | 100% | Mar 2026 |
|
| Vanguard Capital Management | 969k | $10M | 100% | Mar 2026 |
|
| EcoR1 Capital | 733k | $7.8M | 100% | Mar 2026 |
|
| Baker Bros. Advisors | 556k | $5.9M | 100% | Mar 2026 |
|
| Soros Capital Management | 485k | $5.1M | 100% | Mar 2026 |
|
| StepStone | 395k | $4.2M | 100% | Mar 2026 |
|
| Canada Pension Plan Investment Board | 379k | $4.0M | 100% | Mar 2026 |
|
| Franklin Resources | 350k | $3.7M | 100% | Mar 2026 |
|
| Citadel Advisors | 310k | $3.3M | 100% | Mar 2026 |
|
| General Catalyst Group Management | 305k | $3.2M | 100% | Mar 2026 |
|
| Geode Capital Management | 274k | $2.9M | 100% | Mar 2026 |
|
| Jane Street | 265k | $2.8M | 100% | Mar 2026 |
|
| Ensign Peak Advisors | 200k | $2.1M | 100% | Mar 2026 |
|
| Wellington Management Company | 185k | $2.0M | 100% | Mar 2026 |
|
| Millennium Management | 176k | $1.9M | 100% | Mar 2026 |
|
| Blackstone Group | 168k | $1.8M | 100% | Mar 2026 |
|
| Bnp Paribas Investment Partners | 140k | $1.5M | 100% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 132k | $1.4M | 100% | Mar 2026 |
|
| Charles Schwab Investment Management | 131k | $1.4M | 100% | Mar 2026 |
|
| Goldman Sachs Group | 129k | $1.4M | 100% | Mar 2026 |
|
| Comprehensive Financial Management | 116k | $1.2M | 100% | Mar 2026 |
|
| LMR Partners | 115k | $1.2M | 100% | Mar 2026 |
|
| Burkehill Global Management | 115k | $1.2M | 100% | Mar 2026 |
|
| UBS Group | 99k | $1.1M | 100% | Mar 2026 |
|
| Bank of America Corporation | 86k | $911k | 100% | Mar 2026 |
|
| Seven Grand Managers | 80k | $846k | 100% | Mar 2026 |
|
| Ghisallo Capital Management | 70k | $741k | 100% | Mar 2026 |
|
| TD Asset Management | 57k | $604k | 100% | Mar 2026 |
|
| Northern Trust | 46k | $482k | 100% | Mar 2026 |
|
| State Street Corporation | 40k | $425k | 100% | Mar 2026 |
|
| Squarepoint Ops | 31k | $328k | 100% | Mar 2026 |
|
| Manufacturers Life Insurance Company | 29k | $303k | 100% | Mar 2026 |
|
| XTX Topco | 26k | $276k | 100% | Mar 2026 |
|
| Axq Capital | 15k | $163k | 100% | Mar 2026 |
|
| Morgan Stanley | 15k | $162k | 100% | Mar 2026 |
|
| Tudor Investment Corporation | 15k | $159k | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 14k | $145k | 100% | Mar 2026 |
|
| Vanguard Portfolio Management | 14k | $144k | 100% | Mar 2026 |
|
| Hudson Bay Capital Management | 14k | $143k | 100% | Mar 2026 |
|
| Landscape Capital Management | 10k | $110k | 100% | Mar 2026 |
|
| Tower Research Capital | 1.1k | $12k | 100% | Mar 2026 |
|
| Quantbot Technologies | 1.1k | $12k | 100% | Mar 2026 |
|
| Barclays | 318.00 | $3.4k | 100% | Mar 2026 |
|